Celcuity Presents Updated Results from Phase 1b Study of Gedatolisib ...
Celcuity Presents Updated Results from Phase 1b Study of Gedatolisib ...
Source: pr-inside.com
Page 2 - Full Analysis Set News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Full Analysis Set. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Full Analysis Set Today - Breaking & Trending Today
Cassava Sciences (SAVA) Stock: Data For Mild Alzheimer's Good Risk/Reward Profile
Cassava Sciences released data for over 200 patients in an open-label trial at 12 months. The mild AD subgroup performed unprecedentedly. See the outlook here.
Source: seekingalpha.com
Cassava Sciences, Inc. Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease
Cassava Sciences, Inc. announced positive top-line Phase 2 results for simufilam, its oral drug candidate for Alzheimer's disease dementia. This was an open-label safety study with exploratory... | January 25, 2023
Source: marketscreener.com
IRLAB Therapeutics: IRLAB Announces Top-Line Results from Phase IIb Trial of Mesdopetam in Parkinson's disease
GOTHENBURG, SE / ACCESSWIRE / January 17, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) a company discovering and developing novel treatments for Parkinson's disease, today announced the top-line results
Source: finanznachrichten.de
vasopharm GmbH Announces Brain Lactate Microdialysate Data from Post Hoc Analyses of Clinical Trials in Traumatic Brain Injury
Ronopterin significantly reduces lactate levels in brain microdialysate from TBI patients reflecting energetic stability and neuroprotection during the early...
Source: prnewswire.com